Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186444 · ClinicalTrials.gov registry record
Navigator Guided e-Psychoeducational Intervention
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 391
- Enrollment target
NCT02186444: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT02186444 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 391 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02186444 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 391 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of providing newly diagnosed prostate cancer patients and their caregivers with an interactive mobile tablet technology-based application delivered by a community navigator versus providing National Cancer Institute (NCI) information booklets delivered by a Community Navigator (CN) on patient outcomes (decisional satisfaction, quality of life, knowledge, decisional conflict) and shared decision making practices (decision making involvement).
Primary Outcome
Investigators plan to assess if the psycho-educational intervention, PHIN, delivered by a CN is more efficacious as compared to NCI Information Booklets (IB) delivered by a CN. Participants will be asked to complete a baseline set of surveys and follow-up surveys at three additional time points: (1) 6 weeks after receiving the educational intervention; (2) after the follow-up decision with their doctor or health care provider; and (3) 6 months after the baseline surveys were done.
Interventions
- OTHER Personalized Health Information Navigator (PHIN)
- OTHER NCI Information Booklets (IB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 2014-06-02 |
| Est. Completion | 2017-08-17 |
What the finished NCT02186444 record still lists
NCT02186444 is an observational study that tracks outcomes without assigning an intervention. The registered 391 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Personalized Health Information Navigator (PHIN) is the first listed.
NCT02186444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02186444 about?
NCT02186444 is a clinical study titled "Navigator Guided e-Psychoeducational Intervention". The purpose of this study is to evaluate the impact of providing newly diagnosed prostate cancer patients and their caregivers with an interactive mobile tablet technology-based application delivered by a community navigator versus providing National Cancer Institute (NCI) information booklets deliv...
What is the current status of trial NCT02186444?
This trial is currently completed. The enrollment target is 391 participants. The study started on 2014-06-02. Estimated completion is 2017-08-17.
What interventions are being tested in trial NCT02186444?
The interventions under investigation include: Personalized Health Information Navigator (PHIN) (OTHER), NCI Information Booklets (IB) (OTHER).
Who is sponsoring clinical trial NCT02186444?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI